Development and Screening of Contrast Agents for In Vivo Imaging of Parkinson’s Disease

Development and Screening of Contrast Agents for In Vivo Imaging of Parkinson’s Disease

Purpose: The goal was to identify molecular imaging probes that would enter the brain, selectively bind to Parkinson’s disease (PD) pathology, and be detectable with one or more imaging modalities. Procedure: A library of organic compounds was screened for the ability to bind hallmark pathology in...

Full description

Bibliographic Details
Main Authors: Neal, Krista L., Shakerdge, Naomi B., Hou, Steven S., Klunk, William E., Mathis, Chester A., McLean, Pamela J., Bacskai, Brian J., Nesterov, Evgueni, Swager, Timothy M
Other Authors: Massachusetts Institute of Technology. Department of Chemistry
Format: Article
Language:English
Published: Springer US 2016
Online Access:http://hdl.handle.net/1721.1/104658

Internet

http://hdl.handle.net/1721.1/104658

Similar Items